Market Overview
The Global Foam Dressings Market analyses the market size, shares, recent trends, competitive intelligence, and future market outlook. Foam Dressing usage in wound care is on the rise. Demand from Hospitals, Ambulatory Surgical Centres in North America is booming. Competitive rivalry intensifies with ConvaTec Group PLC, Coloplast Corp, Derma Sciences Inc and others operating in the market.
Foam dressings are semipermeable polyurethane material used in wound care. They are non-adherent and non-linting dressings, which only allow water vapor to enter and avoid the entry of bacteria and other contaminants. Foam dressings have expanded the armamentarium of clinicians seeking better dressings for various types of wounds. They rose in popularity in recent years due to the key advantage of providing a moist environment for promoting faster wound healing.
Market Scope
| Metrics | Details |
| Market CAGR | High |
| Segments Covered | By Type, By End User, By Application, and By Region |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
| Fastest Growing Region | Asia Pacific |
| Largest Market Share | North America |
For More Insights Request free Sample
Market Dynamics
The global foam dressings market growth is driven by the growing prevalence of the increasing geriatric population who are more prone to surgeries, growth in awareness about advanced wound care dressings, rising number of road accidents & burns cases, and high prevalence of diabetic wounds & chronic infections.
The rising need for affordable care for patients with chronic and acute wounds will drive the market growth
The rising need for affordable care for patients with chronic and acute wounds in various care settings is a key factor driving the demand for foam dressings in the forecast period. The global foam dressings market is likely to be driven by the rising incidence of pressure injuries in patients of all ages in various parts of the world. The market is likely to see a rapid pace of innovation in foam dressing used to treat pressure ulcers since they hold vast potential in bed sores. Over the past few years, several studies have been made in assessing the clinical relevance and cost-effectiveness of foam dressings in healing pressure injuries. This undoubtedly catalyzes the revenue-generating potential of the foam dressings market. In this regard, polyurethane foam dressings for the prevention of pressure ulcers have gathered considerable attention from researchers and the medical fraternity in general.
Foam dressings are made up of highly absorbent material called hydrophilic polyurethane. The foam helps in absorbing the moisture that aids in maintaining the integrity of the tissue. The increasing cases of burns and trauma in the U.S. are expected to propel the segment growth. For instance, as per the American Burn Association (ABA) in 2016, around 486,000 people were given medical treatment for burning injuries in the U.S. It also reported that complications of infection have accounted to be highest in burn patients. Foams are majorly used to prevent and heal the exudation of burn injuries and hence the increasing cases of such incidents are expected to surge market growth over the forecast period.
The high cost of dressings is likely to hamper the market growth
However, factors such as limited reimbursement policies in emerging countries and high costs of dressings restrain the market growth in the forecast period.
COVID-19 Impact Analysis on Market
The COVID-19 pandemic is expected to have an impact on the foam dressings market. The spread of the COVID-19 has profoundly affected the way to conduct our medical practices, resulting in a decrease in necessary medical care, including the wound healing specialty. The actual period of the COVID-19 pandemic limits the ability to practice wound healing in normal conditions. Patients with vascular leg ulcers represent an extremely vulnerable population, with poor quality of life caused by the pain directly related to both ulcer duration and ulcer area. These patients must not be overlooked because of the irreversible consequences. If ischemic and venous wounds are not treated or managed, the results could be drastic, such as infections, sepsis, amputations, or even fatalities.
Even as lockdowns eased and outpatient appointments resumed, many patients may have chosen to avoid appointments out of fear of exposure to COVID-19.4 Access to wound care has also varied across regions, and localities are given different regulations and restrictions at the state level. These factors hamper the market growth during the pandemic.
Market Segmentation Analysis
The true foam segment is expected to grow at the fastest CAGR during the forecast period (2021-2028)
True foams are commonly composed of polyurethane or silicone, the true foam dressing draws fluid into air spaces via capillary action; they have a hydrophilic contact layer that encourages the fluid to pass through the dressing away from the wound bed. The fluid is then held within the foam structure and the backing of the dressings is designed to allow evaporation of small amounts of fluid, therefore, enhancing the dressing total fluid capacity handling.
The choice of which dressing to use is based on several factors these include the condition of the wound bed and surrounding skin, level of exudate, location, and etiology of the wound, wear time, comfort and conformability, patient’s choice, and ease of use. The advantage of choosing foam dressings for medium to heavily exudating wounds is that they will not shed fibers unlike gauze- or wadding-based products, the ability to manage the exudate levels will prevent surrounding ulcer maceration and dressings strike-through, strikethrough is when the absorbed fluid reaches the outer surface or edge of the dressings, this occurs when the dressings become saturated. True Foam dressings additionally have a non-adherent wound layer ensuring pain-free dressing removal they can be left in place for up to seven days and they can safely be used in a variety of scenarios including under compression bandages, on difficult treat wounds such as diabetic foot ulceration, and infected wounds.
Market Geographical Share
North America region holds the largest market share of the global foam dressings market
North America is expected to hold a major share over the forecast period. The region is expected to witness a considerable growth rate over the forecast period. Increasing road accidents, sports injuries, and the presence of several key players in the region are anticipated to drive the market for foam dressing in the region. In addition, the presence of adequate skilled professionals and highly developed healthcare infrastructure is also expected to drive the market in the region over the forecast period. In recent years, manufacturers in the region have been focusing on improving the performance of foam dressing. They are also bringing advancement in chemistries of the materials used in foam dressings. The advent of such products may help develop specialized wound management solutions. This undoubtedly catalyzes the revenue-generating potential of the foam dressings market.
Companies and Competitive Landscape
The foam dressings Market is moderately competitive with the presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Smith & Nephew PLC, Mölnlycke Health Care AB, ConvaTec Group PLC, Baxter; Coloplast Corp, Medtronic, 3M, Derma Sciences Inc, Medline Industries, Inc. among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the anal fistula globally. For instance, in March 2017, ConvaTec Group PLC launched the Sensi-Care Skin Protectant Incontinence Wipes, which was expected to expand its wound business and increase its market share.
Smith & Nephew PLC
Overview: Smith & Nephew plc is a medical technology company. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.
Product Portfolio:
ALLEVYN: The ALLEVYN Range is divided into the ALLEVYN Classic products, a complete range of clinically proven1-5, quality foam dressings designed to fulfill a diverse range of wound care requirements.
